Thomas D E, Elliott E J, Naughton G A
University of Sydney, Children's Hospital at Westmead, CEBPGAN (Centre for Evidence Based Paediatrics Gastroenterology and Nutrition), Locked Bag 4001, Westmead, Australia, NSW 2145.
Cochrane Database Syst Rev. 2006 Jul 19;2006(3):CD002968. doi: 10.1002/14651858.CD002968.pub2.
BACKGROUND: Exercise is generally recommended for people with type 2 diabetes mellitus. However, some studies evaluate an exercise intervention including diet or behaviour modification or both, and the effects of diet and exercise are not differentiated. Some exercise studies involve low participant numbers, lacking power to show significant differences which may appear in larger trials. OBJECTIVES: To assess the effects of exercise in type 2 diabetes mellitus. SEARCH STRATEGY: Trials were identified through the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE and manual searches of bibliographies. Date of last search was March 3, 2005. SELECTION CRITERIA: All randomised controlled trials comparing any type of well-documented aerobic, fitness or progressive resistance training exercise with no exercise in people with type 2 diabetes mellitus. DATA COLLECTION AND ANALYSIS: Two authors independently selected trials, assessed trial quality and extracted data. Study authors were contacted for additional information. Any information on adverse effects was collected from the trials. MAIN RESULTS: Fourteen randomised controlled trials comparing exercise against no exercise in type 2 diabetes were identified involving 377 participants. Trials ranged from eight weeks to twelve months duration. Compared with the control, the exercise intervention significantly improved glycaemic control as indicated by a decrease in glycated haemoglobin levels of 0.6% (-0.6 % HbA(1c), 95% confidence interval (CI) -0.9 to -0.3; P < 0.05). This result is both statistically and clinically significant. There was no significant difference between groups in whole body mass, probably due to an increase in fat free mass (muscle) with exercise, as reported in one trial (6.3 kg, 95% CI 0.0 to 12.6). There was a reduction in visceral adipose tissue with exercise (-45.5 cm(2), 95% CI -63.8 to -27.3), and subcutaneous adipose tissue also decreased. No study reported adverse effects in the exercise group or diabetic complications. The exercise intervention significantly increased insulin response (131 AUC, 95% CI 20 to 242) (one trial), and decreased plasma triglycerides (-0.25 mmol/L, 95% CI -0.48 to -0.02). No significant difference was found between groups in quality of life (one trial), plasma cholesterol or blood pressure. AUTHORS' CONCLUSIONS: The meta-analysis shows that exercise significantly improves glycaemic control and reduces visceral adipose tissue and plasma triglycerides, but not plasma cholesterol, in people with type 2 diabetes, even without weight loss.
背景:一般建议2型糖尿病患者进行运动。然而,一些研究评估的运动干预包括饮食或行为改变或两者兼而有之,饮食和运动的效果并未区分开来。一些运动研究的参与者数量较少,缺乏显示在更大规模试验中可能出现的显著差异的效力。 目的:评估运动对2型糖尿病的影响。 检索策略:通过Cochrane对照试验中央注册库(CENTRAL)、MEDLINE、EMBASE以及对参考文献的手工检索来识别试验。最后一次检索日期为2005年3月3日。 入选标准:所有将任何类型的有充分记录的有氧运动、健身或渐进性抗阻训练运动与2型糖尿病患者不运动进行比较的随机对照试验。 数据收集与分析:两位作者独立选择试验、评估试验质量并提取数据。与研究作者联系以获取更多信息。从试验中收集任何关于不良反应的信息。 主要结果:确定了14项比较2型糖尿病患者运动与不运动的随机对照试验,涉及377名参与者。试验持续时间从8周到12个月不等。与对照组相比,运动干预显著改善了血糖控制,糖化血红蛋白水平降低了0.6%(-0.6% HbA1c,95%置信区间(CI)-0.9至-0.3;P<0.05)。这一结果在统计学和临床上均具有显著意义。两组全身质量无显著差异,可能是由于一项试验报告运动使去脂体重(肌肉)增加(6.3kg,95%CI 0.0至12.6)。运动使内脏脂肪组织减少(-45.5cm²,95%CI -63.8至-27.3),皮下脂肪组织也减少。没有研究报告运动组有不良反应或糖尿病并发症。运动干预显著增加了胰岛素反应(131 AUC,95%CI 20至242)(一项试验),并降低了血浆甘油三酯(-0.25mmol/L,95%CI -0.48至-0.02)。两组在生活质量(一项试验)、血浆胆固醇或血压方面未发现显著差异。 作者结论:荟萃分析表明,运动能显著改善2型糖尿病患者的血糖控制,减少内脏脂肪组织和血浆甘油三酯,但不会降低血浆胆固醇,即使体重没有减轻。
Cochrane Database Syst Rev. 2006-7-19
Cochrane Database Syst Rev. 2005-7-20
Cochrane Database Syst Rev. 2018-2-6
Cochrane Database Syst Rev. 2022-4-14
Cochrane Database Syst Rev. 2004
Cochrane Database Syst Rev. 2003
Cochrane Database Syst Rev. 2022-6-22
Cochrane Database Syst Rev. 2018-7-24
Cochrane Database Syst Rev. 2018-9-19
Cochrane Database Syst Rev. 2018-2-13
Nat Rev Endocrinol. 2025-6
J Diabetes Res. 2025-2-19
Am J Physiol Endocrinol Metab. 2004-11
Diabetes Care. 2003-11
BMJ. 2003-9-6
Int J Sports Med. 2003-8
Diabetes Res Clin Pract. 2002-5